CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies

作者: Helena A. Engman , Hans Lennernäs , Jan Taipalensuu , Charlotta Otter , Brith Leidvik

DOI: 10.1002/JPS.1123

关键词: MicrosomeP-glycoproteinCytochrome P450BiologyIn vitroMolecular biologyMetaboliteIntestinal epitheliumBiochemistryCaco-2Cell culture

摘要: ABSTRACT The aim of this study was to find a cell culture model the intestinal epithelium for use in studies CYP3A4-mediated first-pass metabolism drugs and also interplay between CYP3A4 P-glycoprotein efflux. For purpose, expression CYP3A4, CYP3A5, MDR1 mRNA studied three lines normal human transformed colonic (Caco-2) origin. Surprisingly, only were induced by 1α,25-dihydroxy vitamin D 3 (D3) express high amounts CYP3A4. In contrast original findings model, monolayer integrity maintained during D3 treatment. Levels CYP3A Caco-2 TC7 cells differed dramatically. highest levels lowest CYP3A5 observed treated passage numbers, resulting CYP3A4/3A5 ratio greater than fourfold higher that seen cells. Functional studies, using probe testosterone, showed activity completely absent uninduced After induction, metabolite produced both (149.4 ± 12.3 86.5 ± 3.8 pmol 6β-OH testosterone/min/mg cellular protein from 75 μM testosterone cells, respectively). maximum velocity ( V max ) apparent Michaelis constant K m 6β-hydroxylation intact monolayers similar those obtained microsomes. Only minor changes when metabolically stable substrate celiprolol used. conclusion, these results show features generally available line American Type Culture Collection make it suitable drug efflux mechanisms.

参考文章(49)
Charles L. Crespi, Bruce W. Penman, Ming Hu, Development of Caco-2 Cells Expressing High Levels of cDNA-Derived Cytochrome P4503A4 Pharmaceutical Research. ,vol. 13, pp. 1635- 1641 ,(1996) , 10.1023/A:1016428304366
Ming Hu, Yiqi Li, Christine M. Davitt, Shiew‐Mei Huang, Kenneth Thummel, Bruce W. Penman, Charles L. Crespi, Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharmaceutical Research. ,vol. 16, pp. 1352- 1359 ,(1999) , 10.1023/A:1018986605929
Shamsi D. Raeissi, Zuyu Guo, Glenn L. Dobson, Per Artursson, Ismael J. Hidalgo, Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine Pharmaceutical Research. ,vol. 14, pp. 1019- 1025 ,(1997) , 10.1023/A:1012197110917
Janice Hunter, Barry H. Hirst, Nicholas L. Simmons, Drug Absorption Limited by P-Glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell Layers Pharmaceutical Research. ,vol. 10, pp. 743- 749 ,(1993) , 10.1023/A:1018972102702
L M Gorham, T Prueksaritanont, L O Tran, K P Vyas, J H Hochman, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells Drug Metabolism and Disposition. ,vol. 24, pp. 634- 642 ,(1996)
Shamsi D. Raeissi, Ismael J. Hidalgo, Juan Segura‐Aguilar, Per Artursson, Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharmaceutical Research. ,vol. 16, pp. 625- 632 ,(1999) , 10.1023/A:1018851919674
S A Wrighton, M Iwasaki, F P Guengerich, M Vandenbranden, D T Molowa, W R Brian, J L Raucy, M A Sari, Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3) Molecular Pharmacology. ,vol. 38, pp. 207- 213 ,(1990)